☆ 4.6 Letter

DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidine

BRITISH JOURNAL OF HAEMATOLOGY (2014)

Journal

BRITISH JOURNAL OF HAEMATOLOGY

Volume 164, Issue 4, Pages 613-616

Publisher

WILEY

DOI: 10.1111/bjh.12660

Keywords

myeloma; epigenetics; gene arrays; gene expression; drug sensitivity prediction

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Biochemical Research Methods

Accurate and highly interpretable prediction of gene expression from histone modifications

Fabrizio Frasca, Matteo Matteucci, Michele Leone, Marco J. Morelli, Marco Masseroli

Summary: This study proposes a novel computational pipeline for accurately and interpretable modeling of gene transcriptional regulation through HM. By extracting insightful gene-specific regulative patterns and comparing with ChromHMM, the method has shown advantages in predicting gene transcriptional states.

BMC BIOINFORMATICS (2022)

Add to Collection

Article Biology

Reassessment of weak parent-of-origin expression bias shows it rarely exists outside of known imprinted regions

Carol A. Edwards, William M. D. Watkinson, Stephanie B. Telerman, Lisa C. Hulsmann, Russell S. Hamilton, Anne C. Ferguson-Smith, Deborah Bourc'his

Summary: In mice and humans, imprinting genes play important roles in development, behavior, and post-natal adaptations. Failure to properly imprint genes in humans is associated with various disorders and diseases. Researchers have used RNA-seq technologies and hybrid mouse strains to identify novel imprinted genes, leading to an increase in reported genes with parental origin-specific expression bias. However, validation experiments show that many of these genes are not genuine imprinted genes and that the mouse strain has a greater influence on expression biases than parental origin.

ELIFE (2023)

Add to Collection

Article Biotechnology & Applied Microbiology

Prediction of on-target and off-target activity of CRISPR-Cas13d guide RNAs using deep learning

Hans-Hermann Wessels, Andrew Stirn, Alejandro Mendez-Mancilla, Eric J. Kim, Sydney K. Hart, David A. Knowles, Neville E. Sanjana

Summary: Accurate prediction of on-target activity and off-target avoidance is crucial for RNA-targeting CRISPR effectors in transcriptome engineering. In this study, we designed and tested over 200,000 RfxCas13d guide RNAs with mismatches and indels. We found that the impact of mismatches and indels on Cas13d activity is dependent on the position and context, and G-U wobble pairings are better tolerated. Using a large-scale dataset, we trained a convolutional neural network called TIGER, which outperforms existing models in predicting efficacy. Combined with specific mismatches, TIGER provides a framework for precise control of gene dosage.

NATURE BIOTECHNOLOGY (2023)

Add to Collection

Article Pharmacology & Pharmacy

Prediction of Drug Targets for Specific Diseases Leveraging Gene Perturbation Data: A Machine Learning Approach

Kai Zhao, Yujia Shi, Hon-Cheong So

Summary: This article presents a novel computational approach for drug target discovery based on machine learning models. The approach integrates expression profiles from drug-induced gene perturbations and predicts targets for specific diseases. The method was validated and showed promising results in identifying known drug targets.

PHARMACEUTICS (2022)

Add to Collection

Article Biochemical Research Methods

Machine Learning for Pharmacogenomics and Personalized Medicine: A Ranking Model for Drug Sensitivity Prediction

Shahabeddin Sotudian, Ioannis Ch Paschalidis

Summary: This study proposes a machine learning approach to predict drug responses based on patient genomic information. The algorithm compares drug-cell line pairs to rank the effectiveness of different drugs on the same cell line. The proposed approach outperforms state-of-the-art methods, even when a large number of drugs and few cell lines are used.

IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Obesity, the other pandemic: linking diet and carcinogenesis by epigenetic mechanisms

Eduardo Izquierdo-Torres, Andres Hernandez-Oliveras, Dalia Lozano-Arriaga, Angel Zarain-Herzberg

Summary: Obesity and cancer are complex medical conditions that are closely related. Understanding the mechanism of obesity and cancer development is crucial for public health. This review article explores the impact of lifestyle on obesity and cancer at the cellular and molecular level, as well as the regulation of gene expression by metabolic products.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2022)

Add to Collection

Letter Oncology

Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups

Eileen M. Boyle, Adam Rosenthal, Hussein Ghamlouch, Yan Wang, Phillip Farmer, Michael Rutherford, Cody Ashby, Michael Bauer, Sarah K. Johnson, Christopher P. Wardell, Yubao Wang, Antje Hoering, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Bart Barlogie, Madhav V. Dhodapkar, Faith E. Davies, Gareth J. Morgan, Frits van Rhee, Brian A. Walker

Summary: Sequencing studies have revealed differences in gene expression between smouldering multiple myeloma (SMM) and symptomatic multiple myeloma (MM), with shared dysregulated genes highlighting the importance of the PRC2.1 complex. Subgroup-specific differences exist even at the SMM stage of disease, suggesting distinct biological features drive progression within each TC molecular subgroup. The data suggest that MMSET SMM has already transformed, while other precursor diseases are distinct clinical entities from their symptomatic counterpart.

LEUKEMIA (2022)

Add to Collection

Review Biochemistry & Molecular Biology

The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications

Anna Pula, Pawel Robak, Damian Mikulski, Tadeusz Robak

Summary: Multiple myeloma is a genetically complex disease with unknown molecular mechanisms for its initiation and heterogeneous evolution. The identification of driver mutations is crucial in understanding the disease and its response to therapy. Gene expression profiling plays an important role in revealing the molecular heterogeneity of multiple myeloma and its clinical relevance.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Biochemical Research Methods

Deep learning for drug response prediction in cancer

Delora Baptista, Pedro G. Ferreira, Miguel Rocha

Summary: This article critically reviews recent studies that have used deep learning methods to predict drug response in cancer cell lines and introduces the characteristics of DL and the architectures used in these studies. It also provides an overview of publicly available drug screening data resources and discusses the limitations of these methods.

BRIEFINGS IN BIOINFORMATICS (2021)

Add to Collection

Article Biochemical Research Methods

An enhanced cascade-based deep forest model for drug combination prediction

Weiping Lin, Lianlian Wu, Yixin Zhang, Yuqi Wen, Bowei Yan, Chong Dai, Kunhong Liu, Song He, Xiaochen Bo

Summary: Combination therapy has shown effective results in treating complex diseases, but the search space for drug combinations is too large to be experimentally validated. Artificial intelligence techniques, particularly machine learning methods, have been used to discover synergistic drug combinations and significantly reduce experimental workload. In this study, a novel approach called EC-DFR is presented to predict synergistic drug combinations in various cancer cell lines by incorporating cell line-specific drug-induced gene expression profiles as features. The EC-DFR outperforms other methods and has been validated through biological experiments. The analysis also highlights the importance of cellular responses of drugs in predicting synergism.

BRIEFINGS IN BIOINFORMATICS (2022)

Add to Collection

Review Plant Sciences

Trichoderma as a powerful fungal disease control agent for a more sustainable and healthy agriculture: recent studies and molecular insights

Amanda O. Rodrigues, Louise L. May L. De Mio, Carlos R. Soccol

Summary: Molecular studies have revealed Trichoderma's biocontrol mechanisms, making it an alternative to pesticides for disease control. Trichoderma-treated plants benefit from disease control and growth promotion through gene expression modulation. The commercialization and industrialization of Trichoderma technologies are increasing worldwide.

PLANTA (2023)

Add to Collection

Review Oncology

Circular RNA as a Novel Biomarker for Diagnosis and Prognosis and Potential Therapeutic Targets in Multiple Myeloma

Alessandro Allegra, Nicola Cicero, Alessandro Tonacci, Caterina Musolino, Sebastiano Gangemi

Summary: Circular RNAs (circRNAs) are closed RNAs that can interact with microRNAs and affect biological systems. CircRNAs expressed in the hematopoietic compartment have been identified as regulators of tumor progression in blood malignancies, making them potential diagnostic and prognostic markers for multiple myeloma.

CANCERS (2022)

Add to Collection

Article Biochemical Research Methods

A cross-level information transmission network for hierarchical omics data integration and phenotype prediction from a new genotype

Di He, Lei Xie

Summary: CLEIT is a novel network framework that aims to address challenges in predicting genotype-phenotype associations by integrating multiple incoherent omics data, learning latent representations of high-level domains, and leveraging unlabeled data to improve generalizability of predictive models. It demonstrates effectiveness in predicting anti-cancer drug sensitivity from somatic mutations with the assistance of gene expressions compared to state-of-the-art methods.

BIOINFORMATICS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Comprehensive analysis of ferroptosis-related genes in immune infiltration and prognosis in multiple myeloma

Quanqiang Wang, Misheng Zhao, Tianyu Zhang, Bingxin Zhang, Ziwei Zheng, Zhili Lin, Shujuan Zhou, Dong Zheng, Zixing Chen, Sisi Zheng, Yu Zhang, Xuanru Lin, Rujiao Dong, Jingjing Chen, Honglan Qian, Xudong Hu, Yan Zhuang, Qianying Zhang, Songfu Jiang, Yongyong Ma

Summary: In this study, we investigated the expression differences and prognostic value of ferroptosis-related genes in multiple myeloma (MM) and developed a ferroptosis risk scoring model. We identified pathways closely related to high-risk groups through gene enrichment analysis. We also evaluated the differences in risk stratification in terms of drug sensitivity and immune patterns and confirmed the expression of marker ferroptosis-related genes in MM.

FRONTIERS IN PHARMACOLOGY (2023)

Add to Collection

Review Biochemical Research Methods

A cross-study analysis of drug response prediction in cancer cell lines

Fangfang Xia, Jonathan Allen, Prasanna Balaprakash, Thomas Brettin, Cristina Garcia-Cardona, Austin Clyde, Judith Cohn, James Doroshow, Xiaotian Duan, Veronika Dubinkina, Yvonne Evrard, Ya Ju Fan, Jason Gans, Stewart He, Pinyi Lu, Sergei Maslov, Alexander Partin, Maulik Shukla, Eric Stahlberg, Justin M. Wozniak, Hyunseung Yoo, George Zaki, Yitan Zhu, Rick Stevens

Summary: To enable personalized cancer treatment, machine learning models have been developed to predict drug response based on tumor and drug features. This study used machine learning to analyze five publicly available cell line-based data sets and rigorously evaluated the model generalizability between different studies. The results showed that a multitasking deep neural network achieved the best cross-study generalizability, with models trained on the CTRP data set providing the most accurate predictions on testing data, and the gCSI data set being the most predictable among the cell line data sets.

BRIEFINGS IN BIOINFORMATICS (2022)

Add to Collection

Article Hematology

PIM2 kinase has a pivotal role in plasmablast generation and plasma cell survival, opening up novel treatment options in myeloma

Marion Haas, Gersende Caron, Fabrice Chatonnet, Stephane Manenti, Elina Alaterre, Julie Devin, Celine Delaloy, Giulia Bertolin, Roselyne Viel, Amandine Pignarre, Francisco Llamas-Gutierrez, Anne Marchalot, Olivier Decaux, Karin Tarte, Laurent Delpy, Jerome Moreaux, Thierry Fest

Summary: The kinase PIM2 plays a crucial role in the differentiation of B cells and in the survival of mature normal and malignant plasma cells. PIM2 regulates the cell cycle and apoptotic processes, affecting the secretion ability and adaptability of plasma cells.

BLOOD (2022)

Add to Collection

Review Economics

Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision Aids

Mimi Choon-Quinones, Dirk Hose, Zoltan Kalo, Tamas Zelei, Jean-Luc Harousseau, Brian Durie, Paul Keown, Mike Barnett, Ivett Jakab

Summary: Decision-aids (DAs) can assist in shared decision-making by providing evidence-based information for healthcare professionals, patients, and caregivers. However, current DAs lack a comprehensive framework of decision factors.

VALUE IN HEALTH (2023)

Add to Collection

Article Oncology

Targeting the β2-adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism

Hatice Satilmis, Emma Verheye, Philip Vlummens, Inge Oudaert, Niels Vandewalle, Rong Fan, Jennifer M. Knight, Nathan De Beule, Gamze Ates, Ann Massie, Jerome Moreaux, Anke Maes, Elke De Bruyne, Karin Vanderkerken, Eline Menu, Erica K. Sloan, Kim De Veirman

Summary: This study investigates the potential therapeutic effects of beta-blockers, specifically targeting the beta(2)-adrenergic receptor, in multiple myeloma treatment. The blockade of beta(2)-adrenergic receptors reduces cell viability, induces apoptosis and autophagy, and modulates cancer cell metabolism. Combining beta(2)AR blockade with other drugs enhances apoptosis in multiple myeloma cells.

JOURNAL OF PATHOLOGY (2023)

Add to Collection

Article Oncology

Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma

Elias K. Mai, Stefanie Huhn, Kaya Miah, Alexandra M. Poos, Christof Scheid, Katja C. Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W. Blau, Mathias Haenel, Hans J. Salwender, Axel Benner, Marc S. Raab, Hartmut Goldschmidt, Niels Weinhold

Summary: Mass spectrometry (MS) is a promising tool for monitoring monoclonal protein in plasma cell dyscrasias. Our study found that MS negativity was significantly associated with improved progression-free survival (PFS) in multiple myeloma patients, even in those patients with complete response (CR). Combining MS and baseline cytogenetics improved the prediction of outcome, and sequential MS combined with baseline disease features and minimal residual disease (MRD) can further improve its clinical value.

BLOOD CANCER JOURNAL (2023)

Add to Collection

Review Economics

Systematic literature review of health economic models developed for multiple myeloma to support future analyses

Mimi Choon-Quinones, Tamas Zelei, Bertalan Nemeth, Manna Toth, Xiao Yang Jia, Mike Barnett, Paul Keown, Brian Durie, Jean-Luc Harousseau, Dirk Hose, Zoltan Kalo

Summary: The aim of this study was to review economic evaluations of health technologies in multiple myeloma (MM) and provide recommendations for future analyses. A systemic literature review was conducted and it was found that most economic analyses were from high-income countries, while evaluations from middle-income countries were rare. Diagnostic technologies and integrated care were rarely modelled, and there was a lack of evaluations regarding minimal residual disease (MRD).

JOURNAL OF MEDICAL ECONOMICS (2023)

Add to Collection

Article Oncology

Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma

Rong Fan, Hatice Satilmis, Niels Vandewalle, Emma Verheye, Philip Vlummens, Anke Maes, Catharina Muylaert, Elke De Bruyne, Eline Menu, Holly Evans, Andrew Chantry, Nathan De Beule, Dirk Hose, Marie Toerngren, Helena Eriksson, Karin Vanderkerken, Ken Maes, Karine Breckpot, Kim De Veirman

Summary: This study reveals the dual therapeutic effects of the immunomodulator tasquinimod in multiple myeloma patients, including inhibition of tumor cell proliferation and promotion of immune activity. The results suggest that tasquinimod can inhibit immunosuppressive myeloid cells in the bone marrow by targeting S100A9, and enhance T cell activity and functionality.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Add to Collection

Article Biochemistry & Molecular Biology

3-O sulfation of syndecan-1 mediated by the sulfotransferase HS3ST3a1 enhances myeloma aggressiveness

L. Baert, B. Manfroi, M. Quintero, O. Chavarria, P. V. Barbon, E. Clement, A. Zeller, T. Van Kuppevelt, N. Sturm, J. Moreaux, A. Tveita, B. Bogen, T. McKee, B. Huard

Summary: Multiple myeloma is a hematological neoplasm derived from plasma cells in the bone marrow. A subpopulation of cells called 10e4(+) cells, which have high resistance to multiple myeloma drugs, bind to the protein APRIL through heparan sulfate chains on syndecan-1. These cells have high proliferation activity and are able to form colonies in 3D cultures. They can develop in the bone marrow after intravenous injection and become more resistant to drugs after treatment. The enzyme HS3ST3a1 plays a role in modifying syndecan-1 to confer reactivity to 10e4 and APRIL binding. Targeting this enzyme could potentially improve drug resistance control in multiple myeloma.

MATRIX BIOLOGY (2023)

Add to Collection

Article Genetics & Heredity

Var divide Decrypt: a novel and user-friendly tool to explore and prioritize variants in whole-exome sequencing data

Mohammad Salma, Elina Alaterre, Jerome Moreaux, Eric Soler

Summary: Var vertical bar Decrypt is a web-based tool designed to extract relevant functional information from whole-exome sequencing (WES) data. It offers various filtering and analysis tools for prioritizing gene variants. By using Var vertical bar Decrypt, we successfully identified known disease oncogenes and novel putative drivers in WES datasets of acute erythroid leukemia patients.

EPIGENETICS & CHROMATIN (2023)

Add to Collection

Article Hematology

Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (CALR) in exon 3

Sarah Bonnet, Serge Carillo, Baptiste Legrand, Barbara Burroni, Thierry Lavabre-Bertrand, Guilhem Requirand, Nicolas Robert, Lea Fornero, Ahmed Al Mansoori, Jerome Moreaux, Guillaume Cartron, Ludovic Gabellier, Charles Herbaux

Summary: This case study describes a patient with extreme thrombocytosis who unfortunately had a rapidly fatal outcome. The cause of the thrombocytosis remained unknown and the patient did not show signs of myelofibrosis. However, dysplastic megakaryocytes were observed. The patient had a novel variant of the CALR gene in exon 3 (C105S), as well as mutations in ASXL1, U2AF1, and EZH2. These mutations were found in myeloid cells but not in lymphoid cells. The patient was diagnosed with a rare case of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN). Due to the high risk of thrombosis, the patient was treated with hydroxycarbamide. As the hematological status worsened, two new mutations, SETBP1 and ETV6, appeared, while the CALR mutation and the three other mutations identified in the chronic stage were still detectable. These findings suggest that the CALR variant may contribute to the pathogenesis of MDS/MPN in this patient.

EUROPEAN JOURNAL OF HAEMATOLOGY (2023)

Add to Collection

Letter Oncology

EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma

Djamila Chemlal, Emmanuel Varlet, Amelie Machura, Sara Ovejero, Guilhem Requirand, Nicolas Robert, Guillaume Cartron, Elina Alaterre, Caroline Bret, Laure Vincent, Charles Herbaux, Giacomo Cavalli, Angelique Bruyer, Hugues De Boussac, Jerome Moreaux

LEUKEMIA (2023)

Add to Collection

Article Medical Laboratory Technology

Immunophenotypic portrait of leukemia-associated-phenotype markers in B acute lymphoblastic leukemia

Emilia Boris, Alexandre Theron, Valentin Montagnon, Nicolas Rouquier, Marion Almeras, Jerome Moreaux, Caroline Bret

Summary: This study aimed to investigate the landscape of 7 leukemia-associated phenotype (LAP) markers in B acute lymphoblastic leukemia (B ALL). The expression levels of these markers in normal leukocytes, normal B cell differentiation, and B lymphoblasts at diagnosis of B ALL were evaluated. The study also examined the prognostic value of these markers using Maxstat R algorithm.

CYTOMETRY PART B-CLINICAL CYTOMETRY (2023)

Add to Collection

Meeting Abstract Oncology

Targeting DNMT3B impairs multiple myeloma cell proliferation and clonogenic capacity and enhances sensitivity to standard of care agents

Catharina Muylaert, Lien Ann Van Hemelrijck, Elina Alaterre, Nicolas Robert, Guilhem Requirand, Kim De Veirman, Eline Menu, Karin Vanderkerken, Jerome Moreaux, Elke De Bruyne

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023)

Add to Collection

Meeting Abstract Oncology

Inhibition of proline production by stromal cells negatively impacts myeloma tumor growth by reducing cytokine and growth factor secretion

Inge Oudaert, Judith Lind, Osman Aksoy, Catharina Muylaert, Hatice Satilmis, Sylvia Faict, Jerome Moreaux, Kim De Veirman, Elke De Bruyne, Sonia Vallet, Karin Vanderkerken, Klaus Podar, Eline Menu

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023)

Add to Collection

Meeting Abstract Oncology

Targeting iron homeostasis in combination with IMiDs as a therapeutic strategy in multiple myeloma

Sara Ovejero, Julie Devin, Tatiana Caneque, Laura Henry, Laura Alibert, Guilhem Requirand, Nicolas Robert, Alizee Steer, Amelie Machura, Christophe Hirtz, Angelique Bruyer, Laure Vincent, Guillaume Cartron, Charles Herbaux, Raphael Rodriguez, Caroline Bret, Jerome Moreaux

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023)

Add to Collection

Meeting Abstract Oncology

Exploiting transcription-replication conflicts as a novel therapeutic intervention in multiple myeloma

Laure Dutrieux, Guillemin Antoine, Lin Yea-Lih, Malik Lutzmann, Guilhem Requirand, Nicolas Robert, Laure, Guillaume Cartron, Charles Herbaux, Raphael Rodriguez, Michel Cogne, Philippe Pasero, Jerome Moreaux

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.